Renalytix PLC at H C Wainwright Global Investment Conference Transcript
Thank you for joining the H.C. Wainwright 24th Annual Global Investment Conference. My name is Lee Chan, and I'm a healthcare analyst at H.C. Wainwright. Today, we have Mr. James McCullough, CEO of Renalytix join us for fireside chat. Welcome, James.
Good afternoon. I'm delighted to be here.
Questions & Answers
So Renalytix markets the KidneyIntelX test for prognosis of kidney [accounts]. Could you tell us what the test measures and how physicians can use that [test result]?
Yeah. So KidneyIntelX is really a program where -- which is based on an in vitro diagnostic. So we take a blood drop. And we measure three circulating proteins, which have a long history in the literature of understanding kidney disease progression. And to that, we add a whole sequence of features from a patient's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |